Heart failure with preserved systolic function;Insuficiência cardíaca com função sistolíca preservada

Arquivos Brasileiros de Cardiologia

Volumn 82, Issue 5, 2004, Pages 494-500

  Tinoco Mesquita, Evandro ^a,b,c   Socrates, Jaderson ^a,b   Rassi, Salvador ^a,b   Villacorta, Humberto ^a,b   Mady, Charles ^a,b  

^a Hospital Pró Cardíaco ^*

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; CARDIOVASCULAR AGENT; CARVEDILOL; IRBESARTAN; NEBIVOLOL; PERINDOPRIL; PLACEBO; RAMIPRIL;

ANEMIA; ARTERIOVENOUS FISTULA; BERIBERI; CARDIOMYOPATHY; ECHOCARDIOGRAPHY; EPIDEMIOLOGICAL DATA; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; PERICARDIAL DISEASE; REVIEW; SYSTOLE; THYROTOXICOSIS; TREATMENT PLANNING; VALVULAR HEART DISEASE;

EID: 3042843647     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2004000500014     Document Type: Review

References (31)

1. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss C, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948-55.
2. Caruana L, Petric MC, Davie AP, Mcmurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from diastolic heart failure or from misdiagnosis? Br Med J 2000; 321: 215-8.
3. Yip GWK, Ho PPY, Woo KS, Sanderson JE. Comparison of frequencies of left ventricular systolic and diastolic heart failure in chinese living in Hong Kong. Am J Cardiol 1999; 84: 563-7.
4. Dauterman KW, Massie BM, Georghiade M. Heart failure associated with preserved systolic function: a common and costly entity. Am Heart J 1998; 135 S: 310-S319.
5. Ceia F, Oliveira AG, et al - Epidemiologia da insuficiência cardíaca e aprendizagem. Rev Port Cardiol 1999; 18: 1151-5.
6. Mosterd A, Cost B et al. The prognosis of heart failure in the general population - the Rotterdam study. Eur J Heart Failure 2001; 22: 1318-27.
7. Senni M, Redfield MM. Heart failure with preserved systolic function - a different natural history? J Am Coll Cadiol 2001; 38: 1277-82.
8. Senni M, Tibouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted Country, Minnesota, in 1991. Circulation 1998; 98: 2282-9.
9. Gottdiener JS, Mc Clelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2001; 137: 631-9.
10. Maghert M, Persson H, Edner M, Kahan T. Epidemiology of heart failure in Sweden - a national survey. Eur heart J 2001; 3: 97-103.
11. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I. Circulation 2002; 105: 1387-93.
12. Zile MR, Brutsaert DL. New concepts in diastolic heart failure: part II. Circulation 2002; 105: 1503-8.
13. Schunkert H, Jackson B, Tang SS, et al. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation 1993; 87: 1328-39.
14. Flesch M, Schiffer F, Zilk O, et al. Angiotensin receptor antagonism and angiotensin converting enzyme inibition improve diastolic dysfunction and Ca(2+) = ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens 1997; 15: 1001-9
15. Yamamoto K, Masuyama T, Sakata Y, et al. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor down regulation and overdrive of the endothelin system. Cardiovasc Res 2000; 46: 421-32
16. Cain BS, Meldrum DR, Joo KS, et al. Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol 1998; 32: 458-67.
17. Del Monte F, Williams E, Lebeche D, et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 2001; 104: 1424-9
18. Watanabe J, Levine MJ, Bellotto F, et al. Left ventricular diastolic chamber stiffness and intramyocardial coronary capacitance in isolated dog hearts. Circulation 1993; 88: 2929-40.
19. Stem S. Angina pectoris without chest pain: clinical implications of silent ischemia. Circulation 2002; 106: 1906-8.
20. Watanabe J, Levine MJ, Bellotto F et al. Effects of coronary venous pressure on left ventricular diastolic distensibility. Circ Res 1990; 67: 923-32.
21. Banerjee P, Banerjee T, Khand A, et al. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002; 39: 138-41.
22. Grossman W. Defining diastolic dysfunction. Circulation 2000; 101: 2020-1.
23. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998; 19: 990-1003.
24. Morroson LK, Harrison A, Drishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39: 202-9.
25. Lubien E, De Maria A, Krishanaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
26. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000; 101: 2118-21.
27. Hunt AS, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Am Coll Cardiol 2001; 38: 2101-13.
28. Revisão das II Diretrizes da Sociedade Brasileira de Cardiologia para o Diagnóstico e Tratamento da Insuficiência Cardíaca. Arq Bras Cardiol 2002; 79 (supl 3).
29. Warner JG Jr., Metzger DC, Kitzman DW, et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33: 1567-72.
30. Kjeldsen SE, Dahlof B, Devereux RB, et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491-8.
31. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.